Health Resources and Services Administration January 12, 2007 – Federal Register Recent Federal Regulation Documents

Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Definition of “Patient”
Document Number: E7-335
Type: Notice
Date: 2007-01-12
Agency: Department of Health and Human Services, Health Resources and Services Administration
Section 602 of Public Law 102-585, the ``Veterans Health Care Act of 1992,'' enacted Section 340B of the Public Health Service (PHS) Act ``Limitation on Prices of Drugs Purchased by Covered Entities.'' Section 340B provides that in order to obtain Medicaid reimbursement for its covered outpatient drugs, a manufacturer must sign a pharmaceutical pricing agreement with the Secretary of Health and Human Services in which the manufacturer agrees to charge a price to covered entities for outpatient drugs that will not exceed an amount determined under a statutory formula. Section 340B is administered as the ``340B Drug Pricing Program'' and is commonly referred to as ``the 340B Program.'' Section 340B states that it is illegal for covered entities to sell medications purchased under the 340B Program to persons who are not considered ``patients'' of the covered entity. The purpose of this notice is to inform interested parties of proposed clarifications to the definition of ``patient'' for whom the covered entity can purchase discounted pharmaceuticals under the 340B Program. This clarification is necessary to protect the integrity of the 340B Program and to assist covered entities and other participants in their compliance efforts.
Notice Regarding 340B Drug Pricing Program-Contract Pharmacy Services
Document Number: E7-334
Type: Notice
Date: 2007-01-12
Agency: Department of Health and Human Services, Health Resources and Services Administration
Section 340B of the Public Health Service Act implements a drug pricing program in which manufacturers who sell covered outpatient drugs to covered entities must agree to charge a price that will not exceed an amount determined under a statutory formula. The purpose of this notice is to inform interested parties of proposed guidelines regarding contract pharmacy services that will allow covered entities to utilize contract pharmacy services arrangements previously limited to the Alternative Methods Demonstration Project program.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.